At Chikujee Therapeutics, we are
developing an entirely new class of
personalized medicines that provide
a cancer cell-specific detection
and/or a tumor marker-specific
targeted therapeutic and cancer
monitoring capabilities to
healthcare professional. The
diagnostics, therapeutic and
monitoring capabilities are
non-invasive and extremely
patient-friendly.
Clinical Biomarkers is key step
on the path to the promise of
personalized medicine.
Clinical monitoring of
cancer biomarkers:
Using an approach that is
similar to detection, the same
cancer biomarkers can be
monitored by monitoring the
intensity of the nanoparticles
within the tumors by
non-invasive methods like MRI.
Examples of applications include
monitoring of ER specific
nanobindi probe to monitor the
clinical efficacy of treatment
by MRI.
